RxDoctor Payments Data

Russell Hendrick, MD

Plastic Surgery · New Orleans, LANPI 1841459369

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 49.3% of the total. That places this record below the midpoint for plastic surgery clinicians in LA, where the typical reported total is $2,768.

$1,178in general payments, 2019–2025

Across 35 payments — averaging $33.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$580
  • Davol Inc.$194
  • Revance Therapeutics, Inc.$122
  • Acumed LLC$114
  • Mentor Worldwide LLC$102
  • Motiva USA, LLC$21
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$1,178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,178 in reported general payments places this provider in the 30th percentile of 49 plastic surgery providers in Louisiana.

See all plastic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$5,069
Medicare patients
18
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin12$98
Tramadol Hcl27$61

Paid to pharmacies, not to this prescriber.

Other plastic surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →